首页> 外文期刊>Oncology letters >Screening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors
【24h】

Screening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors

机译:载脂蛋白A-I作为儿童潜在肝母细胞瘤生物标志物的筛选和鉴定,不包括炎症因子

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of the present study was to identify a child hepatoblastoma serum biomarker that is unaffected by inflammatory factors, with the ultimate aim of finding an effective method for the early diagnosis of hepatoblastoma. The magnetic bead-based weak cation exchange chromatography technique was used to process serum harvested from 30 children with hepatoblastoma, 20 children with systemic inflammatory response syndrome (SIRS) and 20 healthy children. Proteins differentially expressed in SIRS were excluded from consideration as biomarkers for hepatoblastoma. Proteins differentially expressed in hepatoblastoma and healthy controls were screened using surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS). Target proteins were purified by SDS-PAGE, and matrix-assisted laser desorption/ionization (MALDI)-TOF-MS was used to determine their amino acid sequences. Protein matches were searched in the SwissProt database. Quantitative polymerase chain reaction (qPCR) and ELISA were employed to confirm the expression of target proteins. Following screening to exclude inflammatory factors, SELDI-TOF-MS revealed a protein with a mass-to-charge ratio of 9,348 Da that was expressed at significantly lower levels in the serum of children with hepatoblastoma compared with healthy controls (P<0.01). Sequence analysis identified this protein as apolipoprotein A-1 (Apo A-I). qPCR and ELISA confirmed that the expression of Apo A-I mRNA and protein were significantly lower in children with hepatoblastoma compared with healthy controls (P<0.05). These results indicate that Apo A-I is a non-inflammatory protein marker for hepatoblastoma with the potential for use in early diagnosis of hepatoblastoma. In addition, the present study demonstrates the feasibility of proteomic screening for the identification of proteins that can serve as markers for a specific tumor.
机译:本研究的目的是鉴定不受炎症因素影响的儿童肝母细胞瘤血清生物标志物,其最终目的是寻找一种早期诊断肝母细胞瘤的有效方法。基于磁珠的弱阳离子交换色谱技术用于处理30例肝母细胞瘤,20例系统性炎症反应综合征(SIRS)和20例健康儿童的血清。 SIRS中差异表达的蛋白质不被考虑作为肝母细胞瘤的生物标志物。使用表面增强激光解吸/电离飞行时间质谱(SELDI-TOF-MS)筛选肝母细胞瘤和健康对照中差异表达的蛋白质。通过SDS-PAGE纯化目标蛋白,并使用基质辅助激光解吸/电离(MALDI)-TOF-MS确定其氨基酸序列。在SwissProt数据库中搜索蛋白质匹配。定量聚合酶链反应(qPCR)和ELISA被用来确认目标蛋白的表达。在筛选排除炎症因子后,SELDI-TOF-MS揭示了一种质荷比为9,348 Da的蛋白质,与健康对照组相比,它在肝母细胞瘤儿童血清中的表达水平明显降低(P <0.01)。序列分析鉴定该蛋白为载脂蛋白A-1(Apo A-1)。 qPCR和ELISA证实,肝母细胞瘤患儿Apo A-I mRNA和蛋白的表达明显低于健康对照组(P <0.05)。这些结果表明,Apo A-1是肝母细胞瘤的非炎性蛋白标志物,具有用于肝母细胞瘤的早期诊断的潜力。此外,本研究证明了蛋白质组学筛选用于鉴定可以作为特定肿瘤标记物的蛋白质的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号